The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms.
作者信息
Holmström M O, Hjortsø M D, Ahmad S M, Met Ö, Martinenaite E, Riley C, Straten P, Svane I M, Hasselbalch H C, Andersen M H
机构信息
Department of Hematology, Zealand University Hospital, Roskilde, Denmark.
Center for Cancer Immune Therapy, Department of Hematology, Copenhagen University Hospital Herlev, Herlev, Denmark.
出版信息
Leukemia. 2017 Feb;31(2):495-498. doi: 10.1038/leu.2016.290. Epub 2016 Oct 20.
PMID:27761006
Abstract
摘要
Zotero 插件